Axsome Therapeutics Inc

NASDAQ:AXSM  
32.29
-1.06 (-3.18%)
4:14:13 PM EDT: $31.56 -0.73 (-2.26%)
Earnings Announcements

Axsome Therapeutics Reports Third Quarter 2021 Financial Results And Provides Business Update

Published: 11/08/2021 12:30 GMT
Axsome Therapeutics Inc (AXSM) - Axsome Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update.
Q3 Loss per Share $0.93.
Q3 Earnings per Share View $-0.95 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.06 Million
Adjusted EPS is expected to be -$1.02

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.02

More details on our Analysts Page.